Actively Recruiting
Hesperidin RCT in MS
Led by Swansea University · Updated on 2026-03-05
60
Participants Needed
1
Research Sites
53 weeks
Total Duration
On this page
Sponsors
S
Swansea University
Lead Sponsor
B
BioActor B.V.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress. Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.
CONDITIONS
Official Title
Hesperidin RCT in MS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Multiple Sclerosis
- Age 18 years or older
You will not qualify if you...
- Known food allergies, intolerances, or significant gastrointestinal (GI) problems
- Participants under the age of 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
FHMLS, Nutrition Lab
Swansea, Wales, United Kingdom, SA2 8PP
Actively Recruiting
Research Team
H
Hayley Young, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here